Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Alterations in the fibrinolytic cascade post-transplant: evidence of a bimodal expression pattern.

Benza RL, Cavender MA, Barchue J, Tallaj JA, Bourge RC, Kirklin JK, Coffey CS.

J Heart Lung Transplant. 2007 May;26(5):494-7.

2.

Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.

Sartori TM, Maurizio PG, Sara P, Ugolino L, Annalisa A, Panagiotis T, Massimo F, Antonio G.

J Heart Lung Transplant. 1999 Jul;18(7):693-700.

PMID:
10452346
3.

Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation.

Meckel CR, Anderson TJ, Mudge GH, Mitchell RN, Yeung AC, Selwyn AP, Ganz P, Simon DI.

Vasc Med. 1997 Nov;2(4):306-12.

PMID:
9575604
4.

The effect of chronic allograft rejection on plasma regulators of fibrinolysis.

Perkowska A, Elhasade A, Durlik M, Placha G, Gałazka Z, Lao M, Gaciong Z.

Ann Transplant. 2002;7(1):44-51.

5.
6.
7.
9.

Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.

Kittleson MM, Bead V, Fradley M, St John ME, Champion HC, Kasper EK, Russell SD, Wittstein IS, Hare JM.

J Heart Lung Transplant. 2007 May;26(5):498-503.

PMID:
17449420
10.
11.

Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.

DeSouza CA, Jones PP, Seals DR.

Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):362-8.

12.

Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.

Ray MJ, Marsh NA, Hawson GA.

Blood Coagul Fibrinolysis. 1994 Oct;5(5):679-85.

PMID:
7865673
13.

Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.

Walter T, Szabo S, Kazmaier S, Suselbeck T, Borggrefe M, Hoffmeister HM.

Thorac Cardiovasc Surg. 2009 Sep;57(6):368-71. doi: 10.1055/s-0029-1185596. Epub 2009 Aug 25.

PMID:
19707983
14.
15.

[Activation of fibrynolysis in children with chronic B or C hepatitis].

Michalska K, Szaflarska-Popławska A, Dymek G, Kotschy M.

Pol Merkur Lekarski. 2004 Oct;17(100):316-20. Polish.

PMID:
15690691
16.

Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.

Wada T, Gando S, Mizugaki A, Yanagida Y, Jesmin S, Yokota H, Ieko M.

Thromb Res. 2013 Jul;132(1):e64-9. doi: 10.1016/j.thromres.2013.05.010. Epub 2013 May 30.

PMID:
23726093
17.

Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):611-7.

18.

Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.

Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G.

J Clin Endocrinol Metab. 2001 Feb;86(2):732-7.

PMID:
11158038
19.

Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.

Sartori MT, Rigotti P, Marchini F, Spiezia L, Baldan N, Furian L, Varvarikis C, Girolami A.

Transplantation. 2003 Apr 15;75(7):994-8.

PMID:
12698086
20.

Defective fibrinolysis occurs after infrainguinal reconstruction.

Killewich LA, Macko RF, Gardner AW, Cox K, Lilly MP, Flinn WR.

J Vasc Surg. 1997 May;25(5):858-64; discussion 865.

Supplemental Content

Support Center